OncoSec Receives Notice of Allowance from US Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies – BioSpace

OncoSec Receives Notice of Allowance from US Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies  BioSpace

SAN DIEGO and PENNINGTON, N.J., July 29, 2019 /PRNewswire/ — OncoSec Medical Inc.(OncoSec) (NASDAQ:ONCS), a company developing late-stage …